Breast-Cancer Recurrence after Stopping Endocrine Therapy.

Pan H, Gray R, Hayes DF. Breast-Cancer Recurrence after Stopping Endocrine Therapy. N Engl J Med. 2018 03 01; 378(9):870-871.

View in: PubMed

subject areas

Antineoplastic Agents, Hormonal
Breast Neoplasms
Chemotherapy, Adjuvant
Humans
Neoplasm Recurrence, Local
Receptors, Estrogen
Tamoxifen

authors with profiles

Daniel Hayes

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement